Champlain Sports Medicine is categorized under Sports Medicines in Essex Junction, VT and active since 1988.
Champlain Sports Medicine was established in 1988, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Sports Medicines business, which does work in the B2C market, and is classified as a Sports Medicines, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Betty Spar, Office Manager at the company’s single location by writing to 67 Lincoln St Unit 2, Essex Junction, Vermont VT 05452 or by phoning (802) 878-1003. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Champlain Sports Medicine |
| Contact Person: | Betty Spar, Office Manager |
| Address: | 67 Lincoln St Unit 2, Essex Junction, Vermont 05452 |
| Phone Number: | (802) 878-1003 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1988 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Sports Medicines |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Champlain Sports Medicine was started in 1988 to provide professional Sports Medicines under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Betty Spar, Office Manager for inquiries that concern Champlain Sports Medicine by calling the company number (802) 878-1003, as your correspondence is most welcome. Additionally, the physical location of the single location of Champlain Sports Medicine can be found at the coordinates 44.492456,-73.111821 as well as the street address 67 Lincoln St Unit 2 in Essex Junction, Vermont 05452.
For its online presence, you may visit Champlain Sports Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.